NetworkNewsBreaks – Endonovo Therapeutics Inc. (
Post# of 416
(Total Views: 936)
Posted On: 09/30/2019 4:08:35 PM
NetworkNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Appoints Recognized Medical Professional and Business Visionary Dr. William Li as Strategic Advisor to the CEO
Endonovo Therapeutics (OTCQB: ENDV), a commercial-stage developer of noninvasive Electroceutical® therapeutic devices, today announced its appointment of Dr. William Li as Strategic Advisor to the CEO. According to the update, Dr. Li and Endonovo CEO Alan Collier will work collaboratively and strategically to explore growth strategies for the company’s contemplated market segments. “Dr. Li is a globally recognized medical professional and a business visionary with a strong track record of success,” Endonovo CEO Alan Collier said in the news release. “Like us, he takes a long-term view of medical advances and believes industry can play a pivotal role in shaping the future. We look forward to working with Dr. Li to further extend our industry leadership by aligning Endonovo with each of the major market segments we can impact.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Endonovo Therapeutics (OTCQB: ENDV), a commercial-stage developer of noninvasive Electroceutical® therapeutic devices, today announced its appointment of Dr. William Li as Strategic Advisor to the CEO. According to the update, Dr. Li and Endonovo CEO Alan Collier will work collaboratively and strategically to explore growth strategies for the company’s contemplated market segments. “Dr. Li is a globally recognized medical professional and a business visionary with a strong track record of success,” Endonovo CEO Alan Collier said in the news release. “Like us, he takes a long-term view of medical advances and believes industry can play a pivotal role in shaping the future. We look forward to working with Dr. Li to further extend our industry leadership by aligning Endonovo with each of the major market segments we can impact.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Endonovo Therapeutics, Inc. (ENDV) Stock Research Links
Scroll down for more posts ▼